AUM $282.5MER 0.58%NAV $89.98Holdings 31Inception Jun 2005
Price Chart
Key Statistics
Previous Close
$89.94Day Range
$89.66$90.13
52-Week Range
$64.94$93.18
Avg Volume
8.1KDividend Yield
1.03%Expense Ratio
0.58%AUM
$282.5MShares Outstanding
3.1METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 97.11% |
| Netherlands | 2.80% |
| Other | 0.08% |
Fund Information
- Issuer
- Invesco
- Category
- Healthcare
- Inception Date
- Jun 23, 2005
- Exchange
- NYSE_ARCA
- Description
- The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Similar ETFs
The Invesco Biotechnology & Genome ETF (PBE) is an exchange-traded fund issued by Invesco that launched on Jun 23, 2005. It currently manages $282.5M in assets under management. The fund charges an expense ratio of 0.58%. The fund holds 31 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 44.9% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | AMGN | Amgen Inc | 5.00% | 38,102 | $14.2M |
| 2 | RPRX | Royalty Pharma PLC | 4.96% | 237,665 | $14.0M |
| 3 | VRTX | Vertex Pharmaceuticals Inc | 4.91% | 29,366 | $13.9M |
| 4 | BIIB | Biogen Inc | 4.70% | 66,296 | $13.3M |
| 5 | REGN | Regeneron Pharmaceuticals Inc | 4.65% | 20,169 | $13.1M |
| 6 | GILD | Gilead Sciences Inc | 4.43% | 95,721 | $12.5M |
| 7 | CDNA | CareDx Inc | 4.31% | 324,147 | $12.2M |
| 8 | UTHR | United Therapeutics Corp | 4.14% | 22,127 | $11.7M |
| 9 | ALNY | Alnylam Pharmaceuticals Inc | 4.12% | 43,319 | $11.6M |
| 10 | TECH | Bio-Techne Corp | 3.69% | 145,555 | $10.4M |
| 11 | ILMN | Illumina Inc | 3.35% | 48,078 | $9.5M |
| 12 | PTGX | Protagonist Therapeutics Inc | 3.34% | 69,833 | $9.5M |
| 13 | VCYT | Veracyte Inc | 3.23% | 157,932 | $9.1M |
| 14 | VCEL | Vericel Corp | 3.18% | 199,662 | $9.0M |
| 15 | INCY | Incyte Corp | 2.97% | 71,907 | $8.4M |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -0.05% | |
| 1W | -0.10% | |
| 1M | -0.19% | |
| 3M | +12.61% | |
| 6M | +8.78% | |
| YTD | +8.73% | |
| 1Y | +36.06% | |
| 3Y | +40.86% | |
| 5Y | +18.34% |
Moving Averages
20-Day MA
$90.67
Below 20-Day MA50-Day MA
$86.32
Above 50-Day MA200-Day MA
$80.88
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$93.18
Current Price
$89.89
52-Week Low
$64.94
$64.94$93.18
Current Yield
1.03%
Annual Dividend
$0.8667
Frequency
Quarterlyx/year
Last Ex-Date
Mar 23, 2026
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Mar 23, 2026 | $0.0824 | Mar 27, 2026 |
| Dec 22, 2025 | $0.4197 | Dec 26, 2025 |
| Sep 22, 2025 | $0.2341 | Sep 26, 2025 |
| Jun 23, 2025 | $0.1305 | Jun 27, 2025 |
| Mar 24, 2025 | $0.0341 | Mar 28, 2025 |
| Jun 24, 2024 | $0.0082 | Jun 28, 2024 |
| Mar 18, 2024 | $0.0242 | Mar 22, 2024 |
| Jun 20, 2023 | $0.0141 | Jun 23, 2023 |
| Mar 23, 2020 | $0.0290 | Mar 31, 2020 |
| Mar 23, 2020 | $0.0290 | Mar 31, 2020 |
| Sep 24, 2018 | $0.0021 | Sep 28, 2018 |
| Sep 24, 2018 | $0.0020 | Sep 28, 2018 |
| Jun 16, 2017 | $0.2153 | Jun 30, 2017 |
| Jun 16, 2017 | $0.2150 | Jun 30, 2017 |
| Mar 17, 2017 | $0.0560 | Mar 31, 2017 |
| Mar 17, 2017 | $0.0555 | Mar 31, 2017 |
| Dec 16, 2016 | $0.1210 | Dec 30, 2016 |
| Dec 16, 2016 | $0.1208 | Dec 30, 2016 |
| Sep 16, 2016 | $0.0283 | Sep 30, 2016 |
| Sep 16, 2016 | $0.0280 | Sep 30, 2016 |
Dividend Payments Over Time
Category Comparison
| Metric | PBE | Healthcare(212 ETFs) | Momentum(160 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.58% | 0.62% | 0.55% |
| AUM | $282.5M | $1.86B | $1.35B |
| Dividend Yield | 1.03% | 3.66% | 2.53% |
| Avg Volume | 8.1K | 445.6K | 105.6K |
| Holdings | 31 | 147 | 177 |
| Performance | |||
| 1-Month Return | -0.11% | -0.85% | -1.44% |
| 6-Month Return | +17.61% | +12.94% | +12.50% |
| YTD Return | +9.06% | +9.31% | +14.13% |
| 1-Year Return | +17.70% | +14.67% | +16.39% |
Compare with Another ETF
Search for an ETF to compare with PBE:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.